Morning Bid: Inflation, tariffs dominate market landscape
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets. Inflation data from the world’s three largest economies – China, the
Factbox-Who is Andrei Belousov, Putin’s choice as defence minister?
MOSCOW (Reuters) – Russian President Vladimir Putin has proposed a surprise new defence minister, nominating civilian Andrei Belousov, a former deputy prime minister who specialises
Arm plans to launch AI chips in 2025, Nikkei reports
(Reuters) -SoftBank Group’s Arm Holdings plans to develop artificial-intelligence (AI) chips, seeking to launch the first products in 2025, Nikkei Asia reported on Sunday. UK-based
Wildfire evacuation notice issued for oil sands rich Alberta town
TORONTO (Reuters) -An evacuation alert has been issued for Fort McMurray, Alberta, as an out-of-control fire rages southwest of the major Canadian oil town, making
South Korea prepares support package worth over $7 billion for chip industry
SEOUL (Reuters) – South Korea is readying plans for a support package for chip investments and research worth more than 10 trillion won ($7.30 billion),
FBI working towards nabbing Scattered Spider hackers, official says
By Zeba Siddiqui SAN FRANCISCO (Reuters) – The U.S. FBI is working towards charging hackers from the aggressive Scattered Spider criminal gang who are largely
Microsoft hit with $242 million US verdict in Cortana patent lawsuit
By Blake Brittain (Reuters) – Microsoft must pay patent owner IPA Technologies $242 million, a federal jury in Delaware said on Friday after determining that
OpenAI plans to announce Google search competitor on Monday, sources say
By Anna Tong (Reuters) -OpenAI plans to announce its artificial intelligence-powered search product on Monday, according to two sources familiar with the matter, raising the
McDonald’s considering $5 meal deal launch to draw diners, source says
(Reuters) -McDonald’s U.S. franchises are considering launching a $5 meal deal, a source familiar with the matter said on Friday, as the fast-food chain looks
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a